# Clinical Trial in Chinese Healthy Volunteers of GB222

> **NCT04175158** · PHASE1 · UNKNOWN · sponsor: **Genor Biopharma Co., Ltd.** · enrollment: 84 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** GB222
- **BIOLOGICAL:** Bevacizumab

## Key facts

- **NCT ID:** NCT04175158
- **Lead sponsor:** Genor Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-24
- **Primary completion:** 2020-08
- **Final completion:** 2020-11
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2019-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04175158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04175158, "Clinical Trial in Chinese Healthy Volunteers of GB222". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04175158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*